The E2F Pathway Score as a Predictive Biomarker of Response to Neoadjuvant Therapy in ER+/HER2− Breast Cancer

E2F transcription factors play critical roles in the cell cycle. Therefore, their activity is expected to reflect tumor aggressiveness and responsiveness to therapy. We scored 3905 tumors of nine breast cancer cohorts for this activity based on their gene expression for the Hallmark E2F targets gene...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cells
Hlavní autoři: Oshi, Masanori, Takahashi, Hideo, Tokumaru, Yoshihisa, Yan, Li, Rashid, Omar M., Nagahashi, Masayuki, Matsuyama, Ryusei, Endo, Itaru, Takabe, Kazuaki
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI 2020
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7407968/
https://ncbi.nlm.nih.gov/pubmed/32650578
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells9071643
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky